Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC
Status:
Active, not recruiting
Trial end date:
2025-02-01
Target enrollment:
Participant gender:
Summary
This research study is studying a drug called atezolizumab as a possible treatment
HER2-positive metastatic breast cancer (MBC) that has spread to the brain.
The names of the study drugs involved in this study are:
- Atezolizumab
- Pertuzumab
- Trastuzumab